SCHEMBL15788684

SCHEMBL15788684

CCCCOc1cc(N)c(C(F)(F)F)cc1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ S1PR1 P21453 5/20 0.38
▸ BCHE P06276 2/20 0.36
▸ ACHE P22303 2/20 0.36
▸ THRB P10828 3/20 0.36
▸ THRA P10827 2/20 0.36
▸ TLR8 Q9NR97 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ SCN2A Q99250 1/20 0.34
▸ SCN3A Q9NY46 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MAPT P10636 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6232233 0.80 THRA (0.43) CYP1A2CYP2C9CYP2C19THRBTHRA
SCHEMBL399177 0.77 CYP3A4 (0.47) TSHRKDM4EALDH1A1L3MBTL1ALOX15
SCHEMBL10269779 0.76 THRA (0.48) CYP1A2CYP2C9CYP2C19THRBTHRA
SCHEMBL12824961 0.76 MAPK1 (0.41) TSHRMAPTMEN1ALDH1A1KMT2A
SCHEMBL8943023 0.76 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19S1PR1BCHE
SCHEMBL15788383 0.75 ALOX5AP (0.50) S1PR1TSHRMAPTL3MBTL1HTR2C
SCHEMBL13262375 0.75 HTR2A (0.44) CYP1A2CYP2C9CYP2C19S1PR1PTGDR2
SCHEMBL14850371 0.74 PTGDR2 (0.50) S1PR1THRBTHRAMAPTMEN1
SCHEMBL17354126 0.74 PTGDR2 (0.47) CYP1A2CYP2C9CYP2C19MAPTALDH1A1
SCHEMBL10352006 0.74 THRA (0.52) CYP1A2CYP2C9CYP2C19S1PR1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140163011-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-06-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163011-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CYP1A2 2537/4885CYP2C9 2728/4885CYP2C19 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback